browsers
Firefox
messengers
Jappix - Thunderbird
search
Duckduckgo - Quaero - Scroogle
servers
all2all - domaine public - Telekommunisten
networks
Appleseed - Crabgrass - Diaspora - elgg - OneSocialWeb - pip.io
microblog
identi.ca
RELATED SITES
Ada Lovelace Institute - AI Now - Algorithm Watch - Algorithmic Justice League - AlgoTransparency - Atlas of Surveillance - Big Brother Watch - Citizen Lab - Conspiracy Watch - Constantvzw - controle-tes-donnees.net - Data Detox Kit - Digital Freedom Fund - Domaine Public - Do Not Track Electronic Frontier Foundation - europe-v-facebook - Fight for the Future - Forbidden Stories - Gender Shades - Google Spleen - greatfire.org - Guard//Int - hiljade.kamera.rs - Homo Digitalis - Human Rights Watch - Inside Google - Inside Airbnb - Liberties - LobbyPlag - Make Amazon Pay - Manifest-No - Ministry of Privacy - More Perfect Union - myshadow.org - Naked Citizens - Ni pigeons, ni espions - No-CCTV - Non à l’Etat fouineur - Nothing to Hide - noyb - NURPA - Online Nudity Survey - Open Rights Group - Ordinateurs de Vote - Pixel de tracking - Police spies out of lives - Prism Break - Privacy.net - Privacy International - Privacy Project - La Quadrature du Net - Radical AI Project - Reset the Net - Save the Internet - Souriez vous êtes filmés - Sous surveillance - Spyfiles - StateWatch - Stop Amazon - Stop Data Retention - Stop Killer Robots - Stop Spying - Stop The Cyborgs - Stop the Internet Blacklist ! - Stop the Spies - Stop Watching Us - Sur-ecoute.org - Technopolice - Tech Transparency Project - Transparency Toolkit - URME Surveillance - Watching Alibaba - Where are the Eyes ? - Who Targets Me ? - Wikifémia - Wikileaks
From drugs to computers, the big rewards are now in tweaking existing products and presenting them as ground-breaking
For more than a decade, we have been told that the pharmaceutical industry faces a crisis : it finds it more and more difficult to develop new drugs. The returns on research and development, company executives plead, are dismal. In the US particularly they have therefore lobbied for longer periods of patent protection, more government subsidies and less regulation of new (...)